PMID- 31428649
OWN - NLM
STAT- MEDLINE
DCOM- 20200115
LR  - 20200225
IS  - 2314-6141 (Electronic)
IS  - 2314-6133 (Print)
VI  - 2019
DP  - 2019
TI  - Usefulness of Haemoglobin Level Combined with CAMI-STEMI Score for Predicting 
      MACCE in Patients with Acute ST-Elevation Myocardial Infarction after PCI.
PG  - 8534752
LID - 10.1155/2019/8534752 [doi]
LID - 8534752
AB  - Anaemia and high haemoglobin levels are common in ST elevation myocardial 
      infarction (STEMI) patients, but the effect of the haemoglobin level on the 
      prognosis of STEMI patients remains in dispute. This study aimed to evaluate the 
      prognostic value of the haemoglobin level combined with the CAMI-STEMI score in 
      STEMI patients after percutaneous coronary intervention (PCI). We included 360 
      STEMI patients who underwent PCI. The patients were divided into 3 groups 
      according to the first haemoglobin value after PCI. Clinical characteristics and 
      the incidence of major adverse cardiovascular and cerebral events (MACCE) during 
      the follow-up period were recorded. The incidence of MACCE in the 3 groups 
      increased with a decrease in the haemoglobin level. Multivariate regression 
      analysis showed that the CAMI-STEMI score was an independent predictor of MACCE 
      incidence at 30 days after PCI and that anaemia was an independent predictor of 
      MACCE incidence at 6 months and 1 year after PCI. A high haemoglobin level was an 
      independent predictor of MACCE incidence at 1 year after PCI. The area under 
      receiver operating characteristic curves (AUCs) of the haemoglobin level, 
      CAMI-STEMI score, and haemoglobin level combined with CAMI-STEMI score predicting 
      the occurrence of MACCE in STEMI patients within 30 days after PCI were 0.604, 
      0.614, and 0.639, respectively. In conclusion, The CAMI-STEMI score was an 
      independent predictor of MACCE incidence at 30 days after PCI. The haemoglobin 
      level combined with the CAMI-STEMI score improved the predictive value of MACCE 
      in STEMI patients within 30 days after PCI. Trial Registration. This trial was a 
      prospective cohort study and registered with ChiCTR-ROC-17011542.
FAU - Tang, Chengchun
AU  - Tang C
AUID- ORCID: 0000-0003-3767-3551
AD  - Department of Cardiology, Zhongda Hospital, Southeast University, Nanjing, 
      210009, China.
FAU - Luo, Erfei
AU  - Luo E
AD  - Department of Cardiology, Zhongda Hospital, Southeast University, Nanjing, 
      210009, China.
FAU - Wang, Dong
AU  - Wang D
AD  - Department of Cardiology, Zhongda Hospital, Southeast University, Nanjing, 
      210009, China.
FAU - Yan, Gaoliang
AU  - Yan G
AUID- ORCID: 0000-0003-2563-167X
AD  - Department of Cardiology, Zhongda Hospital, Southeast University, Nanjing, 
      210009, China.
FAU - Qiao, Yong
AU  - Qiao Y
AD  - Department of Cardiology, Zhongda Hospital, Southeast University, Nanjing, 
      210009, China.
FAU - Zhu, Boqian
AU  - Zhu B
AD  - Department of Cardiology, Zhongda Hospital, Southeast University, Nanjing, 
      210009, China.
FAU - Liu, Bo
AU  - Liu B
AD  - Department of Cardiology, Zhongda Hospital, Southeast University, Nanjing, 
      210009, China.
FAU - Hou, Jiantong
AU  - Hou J
AUID- ORCID: 0000-0002-7666-7309
AD  - Department of Cardiology, Zhongda Hospital, Southeast University, Nanjing, 
      210009, China.
LA  - eng
PT  - Clinical Trial
PT  - Journal Article
DEP - 20190722
PL  - United States
TA  - Biomed Res Int
JT  - BioMed research international
JID - 101600173
RN  - 0 (Hemoglobins)
SB  - IM
MH  - Aged
MH  - Aged, 80 and over
MH  - *Cerebrovascular Disorders/blood/epidemiology/etiology
MH  - Female
MH  - Follow-Up Studies
MH  - Hemoglobins/*metabolism
MH  - Humans
MH  - Incidence
MH  - Male
MH  - Middle Aged
MH  - *Percutaneous Coronary Intervention
MH  - *Postoperative Complications/blood/epidemiology
MH  - Predictive Value of Tests
MH  - Prospective Studies
MH  - *ST Elevation Myocardial Infarction/blood/epidemiology/surgery
PMC - PMC6679861
COIS- The authors declare that they have no conflicts of interest concerning this 
      paper.
EDAT- 2019/08/21 06:00
MHDA- 2020/01/16 06:00
PMCR- 2019/07/22
CRDT- 2019/08/21 06:00
PHST- 2019/01/03 00:00 [received]
PHST- 2019/06/12 00:00 [revised]
PHST- 2019/07/11 00:00 [accepted]
PHST- 2019/08/21 06:00 [entrez]
PHST- 2019/08/21 06:00 [pubmed]
PHST- 2020/01/16 06:00 [medline]
PHST- 2019/07/22 00:00 [pmc-release]
AID - 10.1155/2019/8534752 [doi]
PST - epublish
SO  - Biomed Res Int. 2019 Jul 22;2019:8534752. doi: 10.1155/2019/8534752. eCollection 
      2019.